Effect of two new immunomodulators on normal and burn injury neutrophils and macrophages.
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D002056:Burns / Q000276:immunology* / Q000628:therapy; D002478:Cells, Cultured; D015232:Dinoprostone; D005260:Female; D006168:Guinea Pigs; D008264:Macrophages / Q000187:drug effects / Q000276:immunology*; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology*; D010446:Peptide Fragments / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011458:Prostaglandins E / Q000032:analysis; D016305:Thymopentin; D013946:Thymopoietins / Q000494:pharmacology*; D013951:Thymus Hormones / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D010446:Peptide Fragments; D010880:Piperidines; D011458:Prostaglandins E; D013946:Thymopoietins; D013951:Thymus Hormones; C038408:CP 46665; D015232:Dinoprostone; D016305:Thymopentin